Apotex will pay $39.1 million while Heritage Pharmaceuticals will contribute $10 million to 50 states and U.S. territories. The settlements, resulting from complaints involving plaintiffs from those states and territories, require both companies to cooperate with multistate litigation in Connecticut District Court, which targets 30 corporate defendants and 25 executives.
The settlements arise from three antitrust complaints against pharmaceutical companies and executives related to different sets of generic drugs. The first trial related to those complaints is set to take place in Hartford, Conn., concerning 80 topical generic drugs that reportedly generated billions in revenue.
Read more here.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
